Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
IR email service
Applicable field (uses covered by this announcement)
IR information dissemination for shareholders and investors
Launch date10 June 2026 (the date on which the decision to launch was announced; the actual service launch date was not specified)
Offering price
Free
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | IR email service |
| Offering price | Free |
| Launch date | 10 June 2026 (the date on which the decision to launch was announced; the actual service launch date was not specified) |
| Applicable area | IR information dissemination for shareholders and investors |
Items this document does not state (14)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enhance constructive dialogue with shareholders and investors and deepen their understanding of the company's business. The need has also grown to communicate in a timely manner its medium- to long-term growth strategy, new service development and responses to revisions to the healthcare system.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.